AVM Biotech
Todd Bertsch is a seasoned financial professional with extensive experience in venture capital and corporate finance. Currently serving as a Venture Partner at VU Venture Partners since 2019, Todd has been instrumental in developing financial models for VC financing and establishing scalable investment processes. As a Strategic Advisor for Zeme and AVM Biotechnology, Todd contributes to innovative strategies in the B2B SaaS and biotech sectors, respectively. Previously, Todd held the position of Managing Director at Weild & Co., where operational enhancements were spearheaded. Additional roles include Founder & CEO of Kinectek, Managing Director at Cowen Inc., and Director at Bank of America Merrill Lynch, where Todd significantly improved operational efficiency and market strategies. Todd holds a Bachelor’s degree in Economics and Political Science from the University of Rochester, and is pursuing an MBA at Purdue Global.
This person is not in any teams
This person is not in any offices
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.